| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Cellular and Molecular Tumor Pathology, CCK, R8: 04 [G. N., Y. X., B. B., O. L.] and Department of Orthopedics [G. N.], Karolinska Hospital, SE-171 76 Stockholm, Sweden; Department of Orthopedics, Stockholm Söder Hospital, SE-100 64 Stockholm, Sweden [B. S.]; Department of Biotechnology, Royal Institute of Technology (KTH), SE-100 44 Stockholm, Sweden [B. B., J. L., M. U.]; and Southern Swedish Regional Tumor Registry [R. P.] and Department of Clinical Genetics [N. M.], University Hospital, SE-221 85 Lund, Sweden
Cytogenetically, synovial sarcoma (SS) is characterized by the translocation t(X;18)(p11.2;q11.2), resulting in a fusion between the SYT gene on chromosome 18 and SSX1 or SSX2 on the X chromosome and the formation of new chimeric genes, SYT-SSX1 or SYT-SSX2. We examined the potential clinical relevance of SYT-SSX1 and SYT-SSX2 fusion transcripts together with tumor proliferation. In a series of 33 patients with primary SS, the type of fusion transcript was assessed by reverse transcription-PCR and sequence analysis. The proliferation rate was analyzed using anti-Ki-67 antibodies. One case carrying an atypical transcript with a 57-bp insert was excluded, leaving 13 SYT-SSX1 and 19 SYT-SSX2 cases for analysis. The hazard ratio (with respect to metastasis-free survival for patients with SYT-SSX1 versus patients with SYT-SSX2 fusion transcripts was 7.4 (95% confidence interval, 1.536; log-rank P = 0.004). There was also an association with reduced overall survival for patients with SYT-SSX1 compared to patients with SYT-SSX2 (hazard ratio, 8.5; 95% confidence interval, 1.073; log-rank P = 0.02). The 5-year metastasis-free survival for patients with SYT-SSX1 was 42% versus 89% for patients with SYT-SSX2. There was a significant association between SYT-SSX1 and a high tumor proliferation rate (P = 0.02). We conclude that the findings suggest that the type of SYT-SSX fusion transcript determines the proliferation rate and is an important predictor of clinical outcome in patients with SS.
This article has been cited by other articles:
![]() |
O. Slater and J. Shipley Clinical relevance of molecular genetics to paediatric sarcomas J. Clin. Pathol., November 1, 2007; 60(11): 1187 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Murphey, M. S. Gibson, B. T. Jennings, A. M. Crespo-Rodriguez, J. Fanburg-Smith, and D. A. Gajewski From the Archives of the AFIP: Imaging of Synovial Sarcoma with Radiologic-Pathologic Correlation RadioGraphics, September 1, 2006; 26(5): 1543 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, L. Yao, T. Ouyang, J. Li, T. Wang, Z. Fan, B. Lin, Y. Lu, and Y. Xie p53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer Clin. Cancer Res., October 15, 2005; 11(20): 7328 - 7333. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guillou and J.-M. Coindre In Reply: J. Clin. Oncol., May 20, 2005; 23(15): 3639 - 3640. [Full Text] [PDF] |
||||
![]() |
T. Hosono, M. Hironaka, A. Kobayashi, H. Yamasawa, M. Bando, S. Ohno, Y. Sohara, and Y. Sugiyama Primary Pulmonary Synovial Sarcoma Confirmed by Molecular Detection of SYT-SSX1 Fusion Gene Transcripts: a Case Report and Review of the Literature Jpn. J. Clin. Oncol., May 1, 2005; 35(5): 274 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Oliveira and C. D.M. Fletcher Molecular Prognostication for Soft Tissue Sarcomas: Are We Ready Yet? J. Clin. Oncol., October 15, 2004; 22(20): 4031 - 4034. [Full Text] [PDF] |
||||
![]() |
L. Guillou, J. Benhattar, F. Bonichon, G. Gallagher, P. Terrier, E. Stauffer, N. de Saint Aubain Somerhausen, J.-J. Michels, G. Jundt, D. R. Vince, et al. Histologic Grade, But Not SYT-SSX Fusion Type, Is an Important Prognostic Factor in Patients With Synovial Sarcoma: A Multicenter, Retrospective Analysis J. Clin. Oncol., October 15, 2004; 22(20): 4040 - 4050. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dennison, E. Weppler, and G. Giacoppe Primary Pulmonary Synovial Sarcoma: A Case Report and Review of Current Diagnostic and Therapeutic Standards Oncologist, June 1, 2004; 9(3): 339 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gaffney, A. Chakerian, J. X. O'Connell, J. Mathers, K. Garner, N. Joste, and D. S. Viswanatha Novel Fluorescent Ligase Detection Reaction and Flow Cytometric Analysis of SYT-SSX Fusions in Synovial Sarcoma J. Mol. Diagn., May 1, 2003; 5(2): 127 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hosaka, Y. Nakashima, K. Kusuzaki, H. Murata, T. Nakayama, T. Nakamata, T. Aoyama, T. Okamoto, K. Nishijo, N. Araki, et al. A Novel Type of EWS-CHOP Fusion Gene in Two Cases of Myxoid Liposarcoma J. Mol. Diagn., August 1, 2002; 4(3): 164 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. O'Sullivan, P. A. Humphrey, L. P. Dehner, and J. D. Pfeifer t(X;18) Reverse Transcriptase-Polymerase Chain Reaction Demonstrating a Variant Transcript J. Mol. Diagn., August 1, 2002; 4(3): 178 - 180. [Full Text] [PDF] |
||||
![]() |
Y. Xie, B. Skytting, G. Nilsson, A. Gasbarri, K. Haslam, A. Bartolazzi, B. Brodin, N. Mandahl, and O. Larsson SYT-SSX Is Critical for Cyclin D1 Expression in Synovial Sarcoma Cells: A Gain of Function of the t(X;18)(p11.2;q11.2) Translocation Cancer Res., July 1, 2002; 62(13): 3861 - 3867. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H.B. Sorensen, J. C. Lynch, S. J. Qualman, R. Tirabosco, J. F. Lim, H. M. Maurer, J. A. Bridge, W. M. Crist, T. J. Triche, and F. G. Barr PAX3-FKHR and PAX7-FKHR Gene Fusions Are Prognostic Indicators in Alveolar Rhabdomyosarcoma: A Report From the Children's Oncology Group J. Clin. Oncol., June 1, 2002; 20(11): 2672 - 2679. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Bijwaard, J. F. Fetsch, R. Przygodzki, J. K. Taubenberger, and J. H. Lichy Detection of SYT-SSX Fusion Transcripts in Archival Synovial Sarcomas by Real-Time Reverse Transcriptase-Polymerase Chain Reaction J. Mol. Diagn., February 1, 2002; 4(1): 59 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ladanyi, C. R. Antonescu, D. H. Leung, J. M. Woodruff, A. Kawai, J. H. Healey, M. F. Brennan, J. A. Bridge, J. R. Neff, F. G. Barr, et al. Impact of SYT-SSX Fusion Type on the Clinical Behavior of Synovial Sarcoma: A Multi-Institutional Retrospective Study of 243 Patients Cancer Res., January 1, 2002; 62(1): 135 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Gebhardt What's New in Musculoskeletal Tumor Surgery J. Bone Joint Surg. Am., April 1, 2001; 83(4): 629 - 629. [Full Text] |
||||
![]() |
T. A. Einhorn and G. P. Nielsen Case 1-2001- A 26-Year-Old Man with a Mass in the Knee N. Engl. J. Med., January 11, 2001; 344(2): 124 - 131. [Full Text] [PDF] |
||||
![]() |
J. Rosai Editorial: Genes and Cancer International Journal of Surgical Pathology, July 1, 2000; 8(3): 175 - 176. [PDF] |
||||
![]() |
M. Ladanyi Diagnosis and Classification of Small Round-Cell Tumors of Childhood Am. J. Pathol., December 1, 1999; 155(6): 2181 - 2182. [Full Text] [PDF] |
||||
![]() |
Y. Xie, B. Skytting, G. Nilsson, B. Brodin, and O. Larsson Expression of Insulin-like Growth Factor-1 Receptor in Synovial Sarcoma: Association with an Aggressive Phenotype Cancer Res., August 1, 1999; 59(15): 3588 - 3591. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |